Submission Details
| 510(k) Number | K220096 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 12, 2022 |
| Decision Date | March 09, 2022 |
| Days to Decision | 56 days |
| Submission Type | Special |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K220096 is an FDA 510(k) clearance for the Genesys Spine 3DP Lumbar Interbody System, a Intervertebral Fusion Device With Bone Graft, Lumbar (Class II — Special Controls, product code MAX), submitted by Genesys Spine (Austin, US). The FDA issued a Cleared decision on March 9, 2022, 56 days after receiving the submission on January 12, 2022. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3080.
| 510(k) Number | K220096 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 12, 2022 |
| Decision Date | March 09, 2022 |
| Days to Decision | 56 days |
| Submission Type | Special |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | MAX — Intervertebral Fusion Device With Bone Graft, Lumbar |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3080 |
| Definition | Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft. |